Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection | Zendy

Soren Gantt | Zendy; François Dionne | Zendy; Frederick K. Kozak | Zendy; Oran Goshen | Zendy; David A. Goldfarb | Zendy; Albert H. Park | Zendy; Suresh B. Boppana | Zendy; Karen B. Fowler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection

Author(s) -

Soren Gantt,

François Dionne,

Frederick K. Kozak,

Oran Goshen,

David A. Goldfarb,

Albert H. Park,

Suresh B. Boppana,

Karen B. Fowler

Publication year - 2016

Publication title -

jama pediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.004

H-Index - 183

eISSN - 2168-6211

pISSN - 2168-6203

DOI - 10.1001/jamapediatrics.2016.2016

Subject(s) - medicine , hearing loss , newborn screening , cytomegalovirus , medicaid , pediatrics , cohort , audiology , health care , human immunodeficiency virus (hiv) , virology , viral disease , herpesviridae , economics , economic growth

Congenital cytomegalovirus (cCMV) infection is a major cause of childhood deafness. Most cCMV infections are not diagnosed without newborn screening, resulting in missed opportunities for directed care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research